Psychopharmacologically active peptides and peptide-derivatives, and the use thereof
AssigneeAkzona Incorporated
InventorsHendrik Marie Greven, David DE Wied
Life of this patent
Estimating the term…
Loading patent…
AssigneeAkzona Incorporated
InventorsHendrik Marie Greven, David DE Wied
Estimating the term…
Biologically active novel peptides and peptide-derivatives of the general formula: ##STR1## where A represents H-(L or D)Met, H-(L or D)Met(.fwdarw.O), H-(L or D)Met(.fwdarw.O.sub.2) desamino-Met, desamino-Met(.fwdarw.O), desamino-Met(.fwdarw.O.sub.2) or the group H.sub.2 N--B--CO--; B represents a branched or straight-chain alkylene (C.sub.1 -C.sub.6) or alkylidene (C.sub.1 -C.sub.6) group; Q represents the amino-acid residue --NH--CHR--CO--; R represents alkyl (C.sub.1 -C.sub.6), p-hydroxyphenylmethyl, 3-indolylmethyl or phenylmethyl; R.sub.1 and R.sub.2 represent hydrogen or an alkyl(1-6C) group, and Z represents N-(phenylalkyl)amino, N-(.beta.-indolylalkyl)amino, L-Trp-OH, L-Phe-OH, L-Trp-Gly-OH or L-Phe-Gly-OH, as well as the functional derivatives thereof.
Compound of the formula:
A pharmaceutical composition having conditioned flight inhibiting psychopharmacological properties, comprising:
The compound:
The compound:
The compound:
The compound:
The compound:
The compound:
The compound:
The compound:
The compound:
Dependencies are inferred from the claim text.